Science
Heart Drug That Cut Lp(a) by 78% Fails to Prevent Heart Attacks in Major Trial
Novartis' pelacarsen did not reduce cardiovascular events in 8,350 patients over five years, a blow to one of cardiology's most anticipated approaches.
Topic
Clinical trial
17 stories from Planck Standard. Latest: November 8, 2026.
- Science
A Tau-Targeting Drug Just Cleared Toxic Tangles From Alzheimer's Brains for the First Time
Biogen's diranersen missed its main goal in a Phase 2 trial but reduced tau pathology and showed signs of slowing decline, enough to push it toward a Phase 3 study.
ScienceOzempic's Key Ingredient Slowed Biological Aging in a First-of-Its-Kind Human Trial
In a randomized study of adults living with HIV, semaglutide cut the pace of biological aging by 9%, the first clinical hint the blockbuster drug may touch aging itself.
ScienceA Kidney Drug Doctors Used Sparingly May Help Millions More, Three Landmark Trials Find
Finerenone slowed kidney decline and cut the risk of heart failure and death across a far wider group of patients than it is prescribed for today — results published simultaneously in The Lancet, NEJM and JAMA.
ScienceWorld-First AI-Designed 'Universal' Coronavirus Vaccine Passes Its First Human Trial
Cambridge researchers and spin-out DIOSynVax report that a vaccine whose key component was designed entirely by machine learning was safe in 39 volunteers and triggered immunity against SARS-CoV-2, SARS-CoV-1 and bat coronaviruses.
ScienceScientists Target 'Undruggable' Pancreatic Cancer Protein and Nearly Double Survival
New drug daraxonrasib reduces death risk by 60% in clinical trial, offering hope for patients with one of medicine's deadliest cancers.
ScienceOne Year of a Single Drug Delayed Rheumatoid Arthritis by Up to Four Years, Trial Finds
A King's College London study found that 12 months of abatacept kept high-risk patients from developing rheumatoid arthritis long after treatment ended, pointing toward a future of preventing the disease rather than just treating it.
MarketsExperimental Lung Cancer Drug Cuts Death Risk by 34% in Major Chinese Trial
Akeso and Summit Therapeutics report breakthrough results for ivonescimab in late-stage study, potentially offering new hope for patients with advanced lung cancer.
ScienceExperimental Weight Loss Drug Delivers Dramatic 28% Body Weight Reduction in Clinical Trial
Eli Lilly's retatrutide injection shows results comparable to gastric bypass surgery among heaviest patients after 80 weeks of treatment.
ScienceAncient Chinese Exercise Lowers Blood Pressure as Effectively as Brisk Walking
Adults with stage 1 hypertension who practiced baduanjin, a gentle 800-year-old mind-body routine, experienced meaningful blood pressure reductions that lasted for an entire year.
- Science
800-Year-Old Chinese Exercise Lowers Blood Pressure as Effectively as Brisk Walking
Adults with stage 1 hypertension who practiced baduanjin saw meaningful drops in blood pressure within three months that lasted for an entire year.
ScienceConstipation Drug Shows Unexpected Power to Protect Kidneys in Clinical Trial
Lubiprostone appears to slow kidney function decline in patients with moderate chronic kidney disease by improving gut bacteria.
- Science
Common Constipation Drug Shows Surprising Power to Protect Kidneys
Clinical trial finds lubiprostone may slow chronic kidney disease by changing gut bacteria that boost spermidine production.
- Science
Constipation Drug Shows Unexpected Power to Slow Chronic Kidney Disease
Clinical trial of 150 patients reveals lubiprostone preserves kidney function by boosting gut bacteria that produce protective compounds, opening new treatment pathways.
ScienceRevolutionary Blood Pressure Drug Shows Promise When Standard Treatments Fail
Baxdrostat reduces blood pressure by nearly 10 mmHg in patients with treatment-resistant hypertension, targeting hormone that causes salt retention.
- Science
Single Gene Therapy Injection Restores Hearing in Deaf Patients Within Weeks
Groundbreaking study shows all ten patients, from toddlers to young adults, experienced improved hearing after receiving working copy of OTOF gene.
- Science
Engineered Antibody Injected Into One Tumor Eliminated Cancer Bodywide
Rockefeller University's redesigned CD40 therapy achieved complete remission in two of 12 patients with metastatic cancer
